Mucosa-Associated Lymphoid Tissue: Guardians of Immunity at Mucosal Frontiers

Main Article Content

Consuelo Alejandra Aguirre González
Hayil Linaldi Sierra
Roberto de Jesus Martinez Camacho
Ruiz Gómez María Fernanda
Marcos Vela Rivera
Francisco Alejandro González Orozco
Sandoval Correa Santiago
Fernando Vázquez Rivera
Mercado Valero Silvia Selene
Torres Esparza Héctor Abraham
Oscar Josué Gómez Romero

Abstract

The mucosa-associated lymphoid tissue (MALT) stands as an intricate and versatile arm of the immune system, positioned strategically at the body's mucosal interfaces. This specialized lymphoid tissue serves as a sentinel against myriad pathogenic challenges while fostering immune tolerance to commensal microorganisms. This article explores the structural and functional attributes of MALT, delving into its critical role in immune surveillance, protection, and homeostasis within mucosal environments. We delve into the intricate interplay between MALT and its cellular constituents, focusing on the lymphocytes, follicular dendritic cells, and the diverse array of immunoglobulins. This comprehensive investigation illuminates the relevance of MALT in the context of infectious diseases, autoimmunity, and inflammation, emphasizing its potential as a therapeutic target. Additionally, we discuss the implications of MALT in the development of mucosal vaccines and the ongoing research avenues poised to unveil novel insights into this remarkable immunological asset.

Article Details

How to Cite
Consuelo Alejandra Aguirre González, Hayil Linaldi Sierra, Roberto de Jesus Martinez Camacho, Ruiz Gómez María Fernanda, Marcos Vela Rivera, Francisco Alejandro González Orozco, Sandoval Correa Santiago, Fernando Vázquez Rivera, Mercado Valero Silvia Selene, Torres Esparza Héctor Abraham, & Oscar Josué Gómez Romero. (2023). Mucosa-Associated Lymphoid Tissue: Guardians of Immunity at Mucosal Frontiers. International Journal of Medical Science and Clinical Research Studies, 3(12), 3256–3261. https://doi.org/10.47191/ijmscrs/v3-i12-58
Section
Articles

References

I. Bertoni F, Zucca E. Delving deeper into MALT lymphoma biology. J Clin Oncol.2006;116:22-6.

II. Farinha P, Gasayne RD. Molecular pathogenesis of mucosaassociated lymphoid tissue lymphoma. J Clin Oncol. 2005;23:6370-8.

III. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood. 2000;96:400-19.

IV. Streubel B, Simonitsch-Klupp I, Müllauer L, Lamprecht A, Huber D, Siebert R, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leuk. 2004;18:1722-6.

V. Decaudin D, De Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood. 2006; 108:1451-60.

VI. Ferreri AJ, Penzoni M, Dognini GP, Du MQ, Doglioni C, Radford J, et al. Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial. Blood. 2006;17:1721-2.

VII. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157-64.

VIII. Zucca E, Cavalli F. Are antibiotics the treatment of choice for gastric lymphoma? Curr Hematol Rep. 2004;3: 11-6.

IX. Gribben J. How I treat indolent lymphoma. Blood.2007;109:4617-26.

X. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol. 2007;136:521-38.

XI. Malfertheiner P, Megraud F, O’morain C, Bazzoli F, ElOmar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-81.

XII. Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M, et al. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer. 1997;79:3-11.

Most read articles by the same author(s)